Gastroprotections of escins Ia, Ib, IIa, and IIb on ethanol-induced gastric mucosal lesions in rats

European Journal of Pharmacology

Volumn 373, Issue 1, 1999, Pages 63-70

  Matsuda, Hisashi ^a   Li, Yuhao ^a   Yoshikawa, Masayuki ^a  

^a KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Capsaicin sensitive afferent neuron; Escin; Ethanol induced gastric lesion; Gastroprotection; Nitric oxide (NO); Prostaglandin; Sympathetic nervous system

Indexed keywords

ALCOHOL; CAPSAICIN; DESACYLESCIN I; DESACYLESCIN II; ESCIN; ESCIN IA; ESCIN IB; ESCIN IIA; ESCIN IIB; INDOMETACIN; N ETHYLMALEIMIDE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; OMEPRAZOLE; PROSTAGLANDIN; SAPONIN; THIOL DERIVATIVE; UNCLASSIFIED DRUG;

ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PYLORUS; RAT; SENSORY NERVE; STOMACH LESION; STOMACH SECRETION; STREPTOZOCIN DIABETES;

ANIMALS; ANTI-BACTERIAL AGENTS; CAPSAICIN; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; ESCIN; ETHANOL; ETHYLMALEIMIDE; GASTRIC MUCOSA; GASTROINTESTINAL AGENTS; INDOMETHACIN; LIGATION; MALE; NG-NITROARGININE METHYL ESTER; PYLORUS; RATS; RATS, SPRAGUE-DAWLEY; STOMACH DISEASES; STREPTOZOCIN;

EID: 0033056370     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(99)00249-6     Document Type: Article

References (48)

1. Ali A.T.M.M. The role of nitric oxide and sulfhydryls in gastric mucosal protection induced by sodium cromoglycate in rats. J. Pharm. Pharmacol. 47:1995;739-743.
2. Anson M.L. The estimation of pepsin, trypsin, papain and cathepsin with hemoglobin. J. Gen. Physiol. 22:1938;79-89.
3. Antoni F., Mauri A., Marinocola F., Resele L.F. Venotonic activity of aescine on the human saphenous vein. Arzneim.-Forsch. 29:1979;672-678.
4. Barrachina M.D., Martinez V., Wang L., Wei J.Y., Taché Y. Synergistic interaction between leptin and cholecystokinin to reduce short-term food intake in lean mice. Proc. Natl. Acad. Sci. USA. 94:1997;10455-10460.
5. 2-antagonists SK and F93479 and oxmetidine and omeprazole. Toxicol. Pathol. 16:1988;288-298.
6. Brown J.F., Tepperman B.L., Hanson P.J., Whittle B.J.R., Momcada S. Differential distribution of nitric oxide synthase between cell fractions isolated from the rat gastric mucosa. Biochem. Biophys. Res. Commun. 184:1992;680-685.
7. Brown J.F., Keates A.C., Hanson P.J., Whittle B.J.R. Nitric oxide generators and cGMP stimulate mucus secretion by rat gastric mucosal cells. Am. J. Physiol. 265:1993;G418-G422.
8. Carlsson E. A review of the effects of long-term acid inhibition in animals. Scand. J. Gastroenterol. 24(166):1989;19. Suppl.
9. Carlsson E., Larsson H., Mattsson H., Ryberg B., Sundell G. Pharmacology and toxicology of omeprazole - with special reference to the effects on the gastric mucosa. Scand. J. Gastroenterol. 21(118):1986;31-38. Suppl.
10. Chaudhury T.K., Robert A. Prevention by mild irritants of gastric necrosis produced in rats by sodium taurocholate. Dig. Dis. Sci. 25:1980;830-836.
11. Clementi G., Caruso A., Cutuli V.M.C., Prato A., Bernardis E., Amico-Roxas M. Effect of amylin in various experimental models of gastric ulcer. Eur. J. Pharmacol. 332:1997;209-213.
12. Di Rosa M., Giroud J.P., Willouhby D.A. Studies of the mediators acute inflammatory response induced in rats in different sites of turpentine. J. Pathol. 104:1971;15-29.
13. Di Rosa M., Ialenti A., Ianaro A., Sautebin L. Interaction between nitric oxide and cyclooxygenase pathways. Prostaglandins, Leukotrienes Essent. Fatty Acids. 54:1996;229-238.
14. Guidobono F., Pagani F., Ticozzi C., Sibilia V., Pecile A., Netti C. Protection by amylin of gastric erosions induced by indomethacin or ethanol in rats. Br. J. Pharmacol. 120:1997;581-586.
15. Holzer P., Sametz W. Gastric mucosal protection against ulcerogenic factors in the rat mediated by capsaicin-sensitive afferent neurons. Gastroenterology. 91:1986;975-981.
16. Inoue K., Hisatomi A., Umeda F., Nawata H. Amylin release from perfused rat pancreas in response to glucose and arginine. Diabetes Res. Clin. Pract. 10:1990;189-192.
17. Kinoshita M., Saito N., Tamaki H. Antisecretory and antiulcer effect of T-330, a novel reversible proton pump inhibitor, in rats. Eur. J. Pharmacol. 321:1997;325-332.
18. Kuratani K., Kodama H., Yamaguchi I. The differential roles of sympathetic nerve activity in the pathogenesis of antral and corpus lesions induced by indomethacin in rats. J. Pharmacol. Exp. Ther. 271:1994;695-702.
19. Lamberts R., Creutzfeldt W., Strüber H.G., Brunner G., Solcia E. Long-term omeprazole therapy in peptic ulcer disease: gastrin, endocrine cell growth, and gastritis. Gastroenterology. 104:1993;1356-1370.
20. Lambrecht N., Trautmann M., Korolkiewicz R., Liszkay M., Peskar B.M. Role of eicosanoids, nitric oxide, and afferent neurons in antacid induced protection in the rat stomach. Gut. 34:1993;329-337.
21. Larner A.J., Lendrum R. Oesophageal candidiasis after omeprazole therapy. Gut. 33:1992;860-861.
22. Larsson H., Carlsson E., Junggren U., Olbe L., Sjöstrand S.E., Skånberg I., Sundell G. Inhibition of gastric acid secretion by omeprazole in the dog and rat. Gastroenterology. 85:1983;900-907.
23. Lindberg P., Brändström A., Wallmark B., Mattsson H., Rikner L., Hoffmann K. Omeprazole: the first proton pump inhibitor. Med. Res. Rev. 10:1990;1-54.
24. Longiave D., Omini C., Nicosias S., Berti F. The mode of action of aescine on isolated veins relationship with prostaglandin F2α Pharmacol. Res. Commun. 10:1979;145-151.
25. Marhuenda E., Martin M.J., Alarcón de la Lastra C. Antiulcerogenic activity of aescine in different experimental models. Phytother. Res. 7:1993;13-16.
26. Marhuenda E., Alarcón de la Lastra C., Martin M.J. Antisecretory and gastroprotective effects of aescine in rats. Gen. Pharmacol. 25:1994;1213-1219.
27. Martin M.J., Marhuenda E., Perez-Guerrero C., Franco J.M. Antiulcer effect of naringin on gastric lesions induced by ethanol in rats. Pharmacology. 49:1994;144-150.
28. Matsuda H., Li Y., Murakami T., Ninomiya K., Yamahara J., Yoshikawa M. Effects of escins Ia, Ib, IIa, and IIb from Horse chestnut, the seeds of Aesculus hippocastanum L., on acute inflammation in animals. Biol. Pharm. Bull. 20:1997;1092-1095.
29. Matsuda H., Murakami T., Li Y., Yamahara J., Yoshikawa M. Mode of action of escins Ia and IIa and E,Z-senegin II on glucose absorption in gastrointestinal tract. Bioorg. Med. Chem. 6:1998;1019-1023.
30. Peskar B.M., Respondek M., Müller K.M., Peskar B.A. A role for nitric oxide in capsaicin-induced gastroprotection. Eur. J. Pharmacol. 198:1991;113-114.
31. 2-blockade and gastric carcinoid tumors in the rats. Gut. 26:1985;1284-1295.
32. Robert A. Cytoprotection by prostaglandins. Gastroenterology. 77:1979;761-767.
33. Robert A., Nezamis J.E., Lancaster C., Hanchar A.J. Cytoprotection by prostaglandins in rats. Prevention of gastric necrosis produced by alcohol, HCl, NaOH, hypertonic NaCl, and thermal injury. Gastroenterology. 77:1979;433-443.
34. Salvemini D., Settle S.L., Masferrer J.L., Seibert K., Currie M.G., Needleman P. Regulation of prostaglandin production by nitric oxide: an in vivo analysis. Br. J. Pharmacol. 114:1995;1171-1178.
35. Sautebin L., Ialenti A., Ianaro A., Di Rosa M. Modulation by nitric oxide of prostaglandin biosynthesis in the rat. Br. J. Pharmacol. 114:1995;323-328.
36. Shay H., Komarov S.A., Fels S.S., Meranze D., Gruenstein M., Siplet H. A simple method for the uniform production of gastric ulceration in the rat. Gastroenterology. 5:1945;43-61.
37. Szabo S., Brown A. Prevention of ethanol-induced vascular injury and gastric mucosal lesions by sucralfate and its components: possible role of endogenous sulfhydryls. Proc. Soc. Exp. Biol. Med. 185:1987;493-497.
38. Szabo S., Trier J.S., Frankel P.W. Sulfhydryl compounds may mediate gastric cytoprotection. Science. 214:1981;200-202.
39. Szelenyi I., Brune K. Possible role of sulfhydryls in mucosal protection induced by aluminum hydroxide. Dig. Dis. Sci. 31:1986;1207-1210.
40. Tarnawski A., Hollander D., Gergely H., Stachura J. Comparison of antacid, sucralfate, cimetidine and ranitidine in protection of gastric mucosa against ethanol injury. Gastroenterology. 84:1983;1331.
41. Whittle B.J.R., Lopez-Belmonte J. Actions and interaction of endothelins, prostacyclin and nitric oxide in the gastric mucosa. J. Physiol. Pharmacol. 44:1993;91-107.
42. Whittle B.J.R., Lopez-Belmonte J., Moncada S. Regulation of gastric mucosal integrity by endogenous nitric oxide: interactions with prostanoids and sensory neuropeptides in the rat. Br. J. Pharmacol. 99:1990;607-611.
43. Wingate D.L. Acid reduction and recurrent enteritis. Lancet. 335:1990;222.
44. Yamamoto O., Okada Y., Okabe S. Effects of a proton pump inhibitor, omeprazole, on gastric secretion and gastric and duodenal ulcers or erosions in rats. Dig. Dis. Sci. 29:1984;394-401.
45. Yoshikawa M., Harada E., Murakami T., Matsuda H., Wariishi N., Yamahara J., Murakami N., Kitagawa I. Escins Ia, Ib, IIa, IIb, and IIIa, bioactive triterpene oligoglycosides from the seeds of Aesculus hippocastanum L.: their inhibitory effects on ethanol absorption and hypoglycemic activity on glucose tolerance test. Chem. Pharm. Bull. 42:1994;1357-1359.
46. Yoshikawa M., Murakami T., Matsuda H., Yamahara J., Murakami N., Kitagawa I. Bioactive saponins and glycosides: III. Horse chestnut. (1) The structures, inhibitory effects on ethanol absorption, and hypoglycemic activity of escins Ia, Ib, IIa, IIb, and IIIa from the seeds of Aesculus hippocastanum L. Chem. Pharm. Bull. 44:1996;1454-1464.
47. Yoshikawa M., Murakami T., Yamahara J., Matsuda H. Bioactive saponins and glycosides: XII. Horse chestnut. (2) Structures of escins IIIb, IV, V, and VI and isoescins Ia, Ib, and V, acylated polyhydroxyoleanene triterpene oligoglycosides, from the seeds of horse chestnut tree (Aesculus hippocastanum L. Hippocastanaceae). Chem. Pharm. Bull. 46:1998;1764-1769.
48. Young J.B., Einhorn D., Landsberg L. Decreased sympathetic (SNS) activity in interscapular brown adipose tissue (IBAT) of streptozotocin-treated rats. Diabetes. 32:1983;26A. Suppl. 1.